Since joining the health system in December 2018, Ms. Osteen has executed a growth plan that included the acquisition of 14 facilities, nine joint ventures with other health systems, and the expansion of multiple facilities and the addition of 1,000 beds. During her tenure, Acadia’s stock price increased 125 percent, generating an increase in value to stockholders of $3.3 billion, a news release said.
Ms. Osteen will continue to serve on the health system’s board of directors and will assist in the selection and transition of the new CEO, according to the news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
